Category Archives: MS Treatment

A drug which has already been approved for the treatment of multiple sclerosis (MS) patients effectively inhibits the coronavirus when tested on human lung cells and, at the same time, fights the immune reaction that is killing COVID-19 patients around the world. In a new study, biomedicine researchers at the Aarhus University (Aarhus, Denmark) have shown that a drug called dimethyl fumarate (DMF), which is approved for the treatment of MS patients, inhibits the growth of a range of viruses in the bodys cells and that this includes the coronavirus (SARS-CoV2) at least when the researchers test it in a test tube. When the pandemic struck, the biomedicine researchers were in the process of testing the effects of a drug which was virtually identical with a particular sclerosis medicine, namely a substance called 4-octyl-itaconate, which is used on e.g. Continue reading →

Roche is focused on finding new treatments and diagnostics that help patients live longer, better lives, and evolve the practice of medicine. By Andrew Humphreys [emailprotected] F. Continue reading →

By Ashley Lyles October 8, 2020 The Science Explained Article In Brief Selective serotonin reuptake inhibitor use following intracerebral hemorrhage was associated with fewer depressive symptoms and an increased risk of recurrent hemorrhagic stroke. Patients treated with selective serotonin reuptake inhibitors (SSRIs) for post-stroke depression following intracerebral hemorrhage (ICH) had fewer depressive symptoms but also have an increased risk of recurrent hemorrhagic stroke, according to a longitudinal cohort study published online on August 31 in JAMA Neurology. SSRIs are generally considered first-line therapies for depression after stroke, the study authors noted, but they are also known to be associated with first-ever ICH risk Continue reading →

Research Nester Market Research Consulting & Industry reports According to Research Nester, Multiple Sclerosis Drugs and Treatment Market in North America region is anticipated to witness largest share in the market on account of presence of highly advanced medical facilities along with large number of research institutions in the region. Multiple Sclerosis Drugs and Treatment Market: Global Demand Analysis & Opportunity Outlook 2027, which delivers detailed overview of the global multiple sclerosis drugs and treatment market in terms of market segmentation by drug, by route of administration, by distribution channel and by region. Further, for thein-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porters five force model Continue reading →

The first grant totals $7.6 million over five years and will fund a study of a pre-dementia condition called motoric cognitive risk syndrome (MCR) in 11,000 older adults living in six countries. Continue reading →

A young Australian woman stranded overseas without the right to work during the coronavirus pandemic was told by her Federal MP to "treat the experience as one of life's big adventures", despite her life savings dwindling and mental health being impacted. Young Sydney woman Chelsea Dorricott, 23, has been stranded in the United Kingdom for months due to the coronavirus pandemic. Continue reading →

[author: Michael Qian] The Supreme Court is abuzz, kicking off a new term this morning and announcing several cert grants last week. Things have been calmer across town at the Federal Circuitwhich, unlike the Supreme Court, has been working all summer. Continue reading →

CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive, a multimedia platform dedicated to providing health care professionals who treat neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, in partnership with the Consortium of Multiple Sclerosis Centers (CMSC), is pleased to announce two upcoming webcast programs on multiple sclerosis (MS) in October. Our partnership with CMSC is leading to extremely important education for neurology professionals everywhere, said Mike Hennessy Jr., president and CEO of MJH Life Sciences, the parent company of NeurologyLive. Through these programs, attendees will get expert perspectives on hot topics in MS that will lead to improved patient care and outcomes Continue reading →

Oct. 8, 2020 05:00 UTC PARIS--(BUSINESS WIRE)-- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of 12 abstracts during the 11th World Congress for Neurorehabilitation (WCNR), taking place virtually between 7-11 October 2020.1-13 Spasticity is a disabling condition in adults and children, characterized by velocity-dependent muscle hyperactivity Continue reading →

ENGLEWOOD Englewood community leader Gwen Johnson is on the road to recovery more than five months after contracting coronavirus. Johnson, known as Ms. Gwen to people in the neighborhood, was diagnosed with COVID-19 in early April Continue reading →